GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results

NEXT STORY
CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
PREV STORY
Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AB Science today announced that an abstract reporting results from its Phase 3 AB09004 study on Alzheimer’s disease has been selected for an oral presentation at the annual Alzheimer’s Association International Conference (AAIC)

author_avatar
NASDAQ Market News

The surgical stapler market was valued at USD 3,300 million in 2018 and is expected to reach USD 4,883.39 million by 2024, with an anticipated CAGR of 6.75%, during the forecast period, 2019

author_avatar
NASDAQ Market News

Roche to present data from one of the most comprehensive oncology portfolios at the 2021 ASCO Annual Meeting showcasing advancements for people living with cancer

author_avatar
NASDAQ Market News